ScreenPoint Medical

ScreenPoint Medical was founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady, world leading experts in quantitative breast image analysis and computer aided detection. They have led research projects in the field for over twenty years and have made important contributions to leading breast imaging products. Prof Karssemeijer says, “I started ScreenPoint Medical because I wanted my academic work to have a greater impact beyond the publication of scientific papers. I knew our work held out the promise to ultimately improve breast cancer survival rates and recognised the huge potential of my university team to develop a really outstanding product. By using the technological advances of Deep Learning Artificial Intelligence, we have overtaken current CAD systems to produce faster and more accurate results.”